EPi-Sense Now Has Embedded Sensing Capability

Innovation allows physicians to direct epicardial ablation on atrium and create lesions on ventricle

 

January 18, 2013
EPi-Sense Guilded Coagulation Device nContact VisiTrax

The VisiTrax cardiac ablation device, EPi-Sense, now has embedded sensing capability. This next generation of technology includes sensors along the ablation device, which provide real-time feedback to physicians conducting cardiac ablation procedures.

The EPi-Sense device and its sensing technology allows electrophysiologists (EPs) to follow epicardial device positioning and lesion creation in real time by utilizing navigational mapping. From a safety perspective, the sensors use electrical feedback to ensure the device is properly positioned on cardiac tissue and energy is directed into the heart. Additionally, by using the sensors during epicardial ablation, the ablated tissue’s electrical impulses can be measured to predict lesion completeness before repositioning the device.

For more information: www.ncontactinc.com.